Epithelial cell‐derived human β‐defensin‐2 acts as a chemotaxin for mast cells through a pertussis toxin‐sensitive and phospholipase C‐dependent pathway

Lehrer, I. R. and Ganz, T. 1999. Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol.11:23.

Boman, H. G. 1995. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol.13:61.

Weinberg, A., Krisanaprakornkit, S. and Dale, B. A. 1998. Epithelial antimicrobial peptides: review and significance for oral applications. Crit. Rev. Oral. Biol. Med.9:399.

Ouellette, A. J. and Selsted, M. E. 1996. Paneth cell defensins: endogenous peptide components of intestinal host defense. FASEB J.10:1280.

Lehrer, R. I., Ganz, T. and Selsted, M. E. 1991. Defensins: endogenous antibiotic peptides of animal cells. Cell64:229.

Fulton, C., Anderson, G. M., Zasloff, M., Bull, R. and Quinn, A. G. 1997. Expression of natural peptide antibiotics in human skin. Lancet350:1750.

Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M. and Wilson, J. M. 1997. Human β‐defensin‐1 is a salt‐sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell88:553.

Valore, E. V., Park, C. H., Quayle, A. J., Wiles, K. R., McCray, P. B., Jr and Ganz, T. 1998. Human β‐defensin‐1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest.101:1633.

Harder, J., Bartels, J., Christophers, E. and Schröder, J.‐M. 1997. A peptide antibiotic from human skin. Nature387:861.

Schröder, J.‐M. 1999. Epithelial peptide antibiotics. Biochem. Pharmacol.57:121.

Bals, R., Wang, X., Wu, Z., Freeman, T., Bafna, V., Zasloff, M. and Wilson, J. M. 1998. Human β‐defensin‐2 is a salt‐sensitive peptide antibiotic expressed in human lung. J. Clin. Invest.102:874.

Harder, J., Bartels, J., Christophers, E. and Schröder, J. M. 2001. Isolation and characterization of human β‐defensin‐3, a novel human inducible peptide antibiotic. J. Biol. Chem.276:5707.

Rothe, M. J., Nowak, M. and Kerdel, F. A. 1990. The mast cell in health and disease. J. Am. Acad. Dermatol.23:615.

Enerback, L., Pipkorn, U. and Granelus, G. 1986. Intraepithelial migration of nasal mucosal mast cells in hay fever. Int. Arch. Allergy. Appl. Immunol.80:44.

Godfrey, H. P., Ilardi, C., Engber, W. and Graziano, F. M. 1984. Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum.27:852.

Gibson, P. G., Allen, C. J., Yang, J. P., Wong, B. J. O., Dolovich, J., Denburg, J. and Hargreave, F. E. 1993. Epithelial mast cells in allergic and nonallergic asthma. Assessment using bronchial brushings. Am. Rev. Respir. Dis.148:80.

Sawada, J., Itakura, A., Tanaka, A., Furusaka, T. and Matsuda, H. 2000. Nerve growth factor functions as a chemoattractant for mast cells through both mitogen‐activated protein kinase and phosphatidylinositol 3‐kinase signaling pathways. Blood95:2052.

Nilsson, G., Butterfield, J. H., Nilsson, K. and Siegbahn, A. 1994. Stem cell factor is a chemotactic factor for human mast cells. J. Immunol.153:3717.

Olsson, N., Piek, E., ten Dijke, P. and Nilsson, G. 2000. Human mast cell migration in response to members of the transforming growth factor‐β family. J. Leuk. Biol.67:350.

Nilsson, G., Johnell, M., Hammer, C. H., Tiffany, H. L., Nilsson, K., Metcalfe, D. D., Siegbahn, A. and Murphy, P. M. 1996. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin‐sensitive signal transduction pathway. J. Immunol.157:1693.

Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schröder, J. M., Wang, J. M., Howard, O. M. Z. and Oppenheim, J. J. 1999. β‐defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science286:525.

Niyonsaba, F., Someya, A., Hirata, M., Ogawa, H. and Nagaoka, I. 2001. Evaluation of the effects of peptide antibiotics human β‐defensins‐1/‐2 and LL‐37 on histamine release and prostaglandin D2 production from mast cells. Eur. J. Immunol.3:1066.

Iwabuchi, K., Nagaoka, I., Someya, A. and Yamashita, T. 1993. Isolation and characterization of the neutrophil‐binding proteins for platelet‐derived adherence‐inhibiting factor. Blood82:1884.

Munson, P. J. and Rodbard, D. 1980. LIGAND: a versatile computerized approach for characterization of ligand‐binding systems. Anal. Biochem.107:220.

Dieu, M. C., Vanbervliet, B., Vicari, A., Bridon, J. M., Oldham, E., Ait‐Yahia, S., Briere, F., Zlotnik, A., Lebecque, S. and Caux, C. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med.188:373.

Yamashiro, S., Wang, J. M., Yang, D., Gong, W. H., Kamohara, H. and Yoshimura T. 2000. Expression of CCR6 and CD83 by cytokine‐activated human neutrophils. Blood96:3958.

Luster, A. D. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med.338:436.

Singh, P. K., Tack, B. F., McCray, P. B., Jr and Welsh, M. J. 2000. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am. J. Physiol. Lung Cell. Mol. Physiol.279:L799.